Organization | Korea Research Foundation

Korea Research Foundation Report issue

Foundation Phase 1 Phase 2

Organization Overview

First Clinical Trial

2009

NCT00879775

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2016

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 2 Trials (2)

caffeine (1 trial)

sodium chloride (1 trial)

Drugs in Phase 1 Trials (5)

cat epidermis allergen (1 trial)

cetirizine (zyrtec) (1 trial)

ciclesonide (alvesco) (1 trial)

dog allergen (1 trial)

house dust mite allergen (1 trial)

Drugs in Other Trials (1)

methylphenidate (ritalin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Cancer Pain (Phase 2)

Rhinitis (Phase 1)

Rhinitis, Allergic (Phase 1)

Overview

Highest Phase: Phase 2
# of Trials: 3
# of Trial APIs: 8